Keyphrases
Aberrant Gene Expression
50%
Acute Lymphoblastic Leukemia
50%
B-lymphoblastic Leukemia
100%
Chemoresistance
100%
Chemosensitivity
100%
Chemotherapy
100%
Combination Pretreatment
50%
Conventional Chemotherapy
50%
Cytotoxicity
50%
Decitabine
100%
DNA Methyltransferase Inhibitor
50%
Epigenetic Agents
50%
Epigenetic Mechanisms
100%
Epigenetic Reprogramming
100%
Gene Expression Profile
50%
Gene Methylation
50%
Gene Signature
100%
Histone Deacetylase Inhibitor (HDACi)
50%
Large Cohort
50%
Leukemia Cell Lines
50%
Methylation Signature
50%
Novel Treatments
50%
Patient Samples
50%
Pediatric Acute Lymphoblastic Leukemia
50%
Poor Outcome
50%
Re-expression
50%
Sample Cell
50%
Specific Genes
100%
Vorinostat
100%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Chemosensitivity
100%
Cytotoxicity
50%
Decitabine
100%
DNA Methyltransferase Inhibitor
50%
Drug Resistance
100%
Epigenetic Mechanism
100%
Gene Expression
100%
Gene Expression Profiling
100%
Histone Deacetylase Inhibitor
50%
Leukemia Cell Line
50%
Lymphoid Leukemia
100%
Methylation
50%
Pediatrics
50%
Vorinostat
100%
Biochemistry, Genetics and Molecular Biology
Chemosensitivity
100%
Cytotoxicity
50%
Decitabine
100%
DNA Methyltransferase
50%
Drug Resistance
100%
Epigenetic Mechanism
100%
Epigenetics
100%
Gene Expression
100%
Gene Expression Profiling
100%
Histone Deacetylase
50%
Methylation
50%
Reprogramming
100%
Immunology and Microbiology
Chemosensitivity
100%
Cytotoxicity
50%
Drug Resistance
100%
Epigenetic Mechanism
100%
Gene Expression
100%
Gene Expression Assay
100%
Histone
50%
Leukemia Cell Line
50%
Methylation
50%
Pretreatment
50%
Vertebral Column
50%
Neuroscience
Cell Line
33%
Cytotoxicity
33%
Decitabine
66%
DNA Methyltransferase
33%
Drug Resistance
66%
Epigenetic Mechanism
66%
Gene Expression
100%
Histone Deacetylase Inhibitor
33%
Methylation
33%
Reprogramming
100%
Vertebral Column
33%
Vorinostat
66%